Cervical Vestibular Evoked Myogenic Potentials in Recurrent and Persistant Benign Paroxysmal Positional Vertigo
NCT ID: NCT05922774
Last Updated: 2023-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2023-06-19
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question\[s\] it aims to answer are:
* Is there any difference between the cVEMP findings of diseased ears of recurrent and nonrecurrent BPPV cases?
* Is there any difference between the cVEMP findings of diseased ears and healthy ears of BPPV patients
* Is there any difference between the cVEMP findings of healthy ears of recurrent and nonrecurrent BPPV cases and healthy controls?
Patients with VNG confirmed BPPV will be recruited and CVEMP test will be performed before the therapeutic manuevers.
Control visits will be scheduled on the 7th day after the therateutic menuevers are performed.
Patients will be followed-up for 4 weeks after the resolution of symptoms. Researchers will compare recurrent (Group 1), nonrecurrent (group 2) BPPV patients and healthy controls (Group 3) to see if there is any difference between the cVEMP findings of two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Tests for Patients With Benign Paroxysmal Positional Vertigo
NCT05141734
Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials
NCT03049683
Vestibular Evoked Myogenic Potentials in Benign Paroxysmal Positional Vertigo (VEMP in BPPV)
NCT01004913
The Effect of Head Tilt and Soft Surface on Virtual SVV in Normal Subjects
NCT04396132
Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical)
NCT04087044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients with recurrent BPPV
Cervical VEMP testing
cervical vestibular evoked myogenic potentials
Group 2
Patients with non recurrent BPPV
Cervical VEMP testing
cervical vestibular evoked myogenic potentials
Group 3
Healthy controls
Cervical VEMP testing
cervical vestibular evoked myogenic potentials
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cervical VEMP testing
cervical vestibular evoked myogenic potentials
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients with recurrent or resistant BPPV
* patients with spontaneous nystagmus
* vestibular or neurologic disorders other than BPPV
* patients who use medication which may affect the vestibular system or muscle tone
* cervical muscle disorders and ocular pathologies which may affect the VEMP results
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haseki Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ISIL TAYLAN CEBI
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haseki Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Karatas A, Yuce T, Cebi IT, Acar Yuceant G, Haci C, Salviz M. Evaluation of Cervical Vestibular-Evoked Myogenic Potential Findings in Benign Paroxysmal Positional Vertigo. J Int Adv Otol. 2016 Dec;12(3):316-320. doi: 10.5152/iao.2016.2170. Epub 2016 Aug 1.
Yetiser S, Ince D, Gul M. An analysis of vestibular evoked myogenic potentials in patients with benign paroxysmal positional vertigo. Ann Otol Rhinol Laryngol. 2014 Oct;123(10):686-95. doi: 10.1177/0003489414532778. Epub 2014 May 1.
Xu H, Liang FY, Chen L, Song XC, Tong MC, Thong JF, Zhang QQ, Sun Y. Evaluation of the utricular and saccular function using oVEMPs and cVEMPs in BPPV patients. J Otolaryngol Head Neck Surg. 2016 Feb 9;45:12. doi: 10.1186/s40463-016-0125-7.
Kim EJ, Oh SY, Kim JS, Yang TH, Yang SY. Persistent otolith dysfunction even after successful repositioning in benign paroxysmal positional vertigo. J Neurol Sci. 2015 Nov 15;358(1-2):287-93. doi: 10.1016/j.jns.2015.09.012. Epub 2015 Sep 5.
Vaduva C, Esteban-Sanchez J, Sanz-Fernandez R, Martin-Sanz E. Prevalence and management of post-BPPV residual symptoms. Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1429-1437. doi: 10.1007/s00405-018-4980-x. Epub 2018 Apr 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cVEMP in intractable BPPV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.